Variables | Univariate analysis | Multivariate analysis | ||
Hazard Ratio (95% CI) | P-value | Hazard Ratio (95% CI) | P-value | |
Age (1 year increase) | 1.02 (0.98 - 1.06) | 0.4 | - | - |
Male (vs. female) | 2.25 (0.84 - 6.29) | 0.1 | - | - |
Visceral fat area (10 cm2 increase) | 1.15 (1.07 - 1.23) | 0.0001 | 1.01 (1.00 - 1.02) | 0.3 |
Subcutaneous fat area (10 cm2 increase) | 1.04 (1.00 - 1.08) | 0.04 | 1.00 (0.99 - 1.00) | 0.1 |
IMT (1 mm increase) | 1.72 (1.03 - 2.63) | 0.04 | 0.93 (0.27 - 2.22) | 0.9 |
eGFR (10 mL/min/1.73 m2 increase) | 0.52 (0.38 - 0.69) | <0.0001 | 0.63 (0.36 - 1.01) | 0.1 |
Hemoglobin (1 g/dL increase) | 0.69 (0.48 - 0.96) | 0.03 | 1.45 (0.93 - 2.31) | 0.1 |
Serum Albumin (1 g/dL increase) | 0.27 (0.13 - 0.67) | 0.001 | 0.33 (0.10 - 1.38) | 0.1 |
UACR (10 mg/g creatinine increase) | 1.02 (1.01 - 1.03) | <0.0001 | 1.02 (1.01 - 1.03) | 0.0005 |
Hypertension (vs. no) | 1.87 (0.65 - 6.70) | 0.3 | - | - |
Hypercholesterolemia (vs. no) | 1.40 (0.51 - 4.44) | 0.5 | - | - |
Hypertriglyceridemia (vs. no) | 1.22 (0.44 - 3.87) | 0.7 | - | - |
Diabetes mellitus (vs. no) | 5.93 (2.21 - 16.6) | 0.0006 | 8.61 (2.11 - 40.4) | 0.003 |
Hyperuricemia (UA ≥ 7.1 mg/dL) (vs. no) | 14.27 (5.25 - 42.3) | <0.0001 | 8.07 (2.25 - 33.3) | 0.001 |